Abstract: The article focuses on the use of stellate ganglion block (SGB) as a potential treatment for posttraumatic stress disorder (PTSD) in military service members. PTSD is a prevalent condition among veterans, often resulting from combat exposure, and can lead to significant emotional and relational difficulties. Traditional treatments, including psychotherapy and pharmacotherapy, may not be sufficient for all individuals, highlighting the need for alternative therapies like SGB, which involves injecting anesthetic into the stellate ganglion to alleviate symptoms. While SGB has shown promise in reducing PTSD symptoms, further research, including larger randomized controlled trials, is necessary to establish its efficacy and standardize its use in treatment protocols.